Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Karma, P.
Right arrow Articles by Löth, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karma, P.
Right arrow Articles by Löth, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1991) 27, 83-90
© 1991 The British Society for Antimicrobial Chemotherapy


research-article

The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis

P. Karmaa, J. Pukandera, M. Penttiläa, J. Ylikoskib, S. Savolainenb, L. Olénc, I. Melénd and S. Löthd

a Department of Otolaryngology, Tampere University Central Hospital SF-33520, Tampere, Finland b Department of Otolaryngology, Military Central Hospital Helsinki, Finland c Department of Otolaryngology, Lidköping Hospital Lidköping, Sweden d Department of Otolaryngology Kärnhospital, Skövde, Sweden


The efficacy and safety of clarithromycin and amoxycillin in the treatment of acute maxillary sinusitis were compared in a single-blind, multicentre outpatient study. Fifty patients were randomly assigned to receive either clarithromycin 500 mg 12-hourly or amoxycillin 500 mg 8-hourly orally. Clinical signs and symptoms, sinus culture and blood and urine laboratory profiles were assessed prior to treatment, at four to six days during treatment, and within 48 h of the end of therapy (usually 9–11 days). Patients from whom β-lactamase producing strains were isolated were excluded from the study. Both antibiotics achieved a clinical success rate of 91% within 48 h post-treatment; radiological resolution or improvement was observed in 91% of patients treated with clarithromycin and 89% of patients who received amoxycillin. Bacteriological cure was achieved in 88% and 91% of evaluable patients for clarithromycin and amoxycillin, respectively. Adverse events were reported for 16% of patients in the clarithromycin group compared to 26% in the amoxycillin group. Gastrointestinal disturbance was the most commonly occurring adverse event in both groups. The results of this study suggest that clarithromycin is as effective and well tolerated as amoxycillin in the treatment of acute maxillary sinusitis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
JAMAHome page
J. W. Williams Jr, D. R. Holleman Jr, G. P. Samsa, and D. L. Simel
Randomized Controlled Trial of 3 vs 10 Days of Trimethoprim/Sulfamethoxazole for Acute Maxillary Sinusitis
JAMA, April 5, 1995; 273(13): 1015 - 1021.
[Abstract] [PDF]


Home page
Arch Fam MedHome page
D. R. Holleman Jr, J. W. Williams Jr, and D. L. Simel
Usual Care and Outcomes in Patients With Sinus Complaints and Normal Results of Sinus Roentgenography
Arch Fam Med, March 1, 1995; 4(3): 246 - 251.
[Abstract] [PDF]


Home page
Arch Fam MedHome page
K. H. Calhoun and J. A. Hokanson
Multicenter Comparison of Clarithromycin and Amoxicillin in the Treatment of Acute Maxillary Sinusitis
Arch Fam Med, August 1, 1993; 2(8): 837 - 840.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
J. B. Friedman
New Macrolide Antibiotics
Ann Intern Med, September 15, 1992; 117(6): 533 - 534.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.